'the FDA agreed that Revive Therapeutics may unblind the pre-dose-selection data for the first 210 patients of the study"
Wasn't the dosage not decided until 400 patients? I could definitely be mistaken, but I thought I remembered them not deciding on the higher dosage until after 400.